Literature DB >> 14551607

Polymorphisms of innate immunity genes and susceptibility to lymphatic filariasis.

A G Hise1, F E Hazlett, M J Bockarie, P A Zimmerman, D J Tisch, J W Kazura.   

Abstract

We examined 906 residents of an area of Papua New Guinea where bancroftian filariasis is endemic for genetic polymorphisms in three innate immunity genes suspected of contributing to susceptibility to infection and lymphatic pathology. Active infection was confirmed by the presence of blood-borne microfilariae and circulating filarial antigen in plasma. Disease was ascertained by physical examination for the presence of overt lymphedema (severe swelling of an arm or leg) or hydrocele. There was no association of infection status, lymphedema of an extremity, or hydrocele with chitotriosidase genotype (CHIT1). Polymorphisms of toll-like receptor-2 and toll-like receptor-4 genes (TLR4 A896G; TLR2 T2178A, G2258A) were not detected (N=200-625 individuals genotyped) except for two individuals heterozygous for a TLR2 mutation (C2029 T). These results indicate that a CHIT1 genotype associated previously with susceptibility to filariasis in residents of southern India and TLR2 and TLR4 polymorphisms do not correlate with infection status or disease phenotype in this Melanesian population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551607     DOI: 10.1038/sj.gene.6364015

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  16 in total

1.  Human chitotriosidase polymorphisms G354R and A442V associated with reduced enzyme activity.

Authors:  Pauline Lee; Jill Waalen; Karen Crain; Aaron Smargon; Ernest Beutler
Journal:  Blood Cells Mol Dis       Date:  2007-08-10       Impact factor: 3.039

Review 2.  Human Genetic Variation and HIV/AIDS in Papua New Guinea: Time to Connect the Dots.

Authors:  Rajeev K Mehlotra
Journal:  Curr HIV/AIDS Rep       Date:  2018-12       Impact factor: 5.071

3.  Chitotriosidase deficiency: a mutation update in an african population.

Authors:  Silke Arndt; Angela Hobbs; Iain Sinclaire; Anthony B Lane
Journal:  JIMD Rep       Date:  2012-12-29

Review 4.  Immunopathogenesis of lymphatic filarial disease.

Authors:  Subash Babu; Thomas B Nutman
Journal:  Semin Immunopathol       Date:  2012-10-03       Impact factor: 9.623

5.  Does 24bp Duplication of Human CHIT1 Gene (Chitotriosidase1) Predispose to Filarial Chyluria? A Case-Control Study.

Authors:  Shriya Pant; Jyotsna Agarwal; Apul Goel; Pravin K Gangwar; Mohammad Waseem; Prashant Gupta; Satya N Sankhwar; Bimalesh Purkait
Journal:  J Clin Diagn Res       Date:  2016-09-01

6.  A preliminary assessment of Toll-like receptor and β-defensin gene polymorphisms in Papua New Guinea - what does it mean for HIV/AIDS?

Authors:  Barne Willie; Janet Gare; Christopher L King; Peter A Zimmerman; Rajeev K Mehlotra
Journal:  P N G Med J       Date:  2017 Mar-Jun

7.  Association between mannose-binding lectin polymorphisms and Wuchereria bancrofti infection in two communities in North-Eastern Tanzania.

Authors:  Dan W Meyrowitsch; Paul E Simonsen; Peter Garred; Michael Dalgaard; Stephen M Magesa; Michael Alifrangis
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

8.  The potential role of toll-like receptor 4 Asp299Gly polymorphism and its association with recurrent cystic echinococcosis in postoperative patients.

Authors:  Jafar Noori; Adel Spotin; Ehsan Ahmadpour; Mahmoud Mahami-Oskouei; Homayoun Sadeghi-Bazargani; Tohid Kazemi; Ebrahim Sakhinia; Leili Aghebati-Maleki; Firooz Shahrivar
Journal:  Parasitol Res       Date:  2018-03-30       Impact factor: 2.289

9.  Toll-like receptor polymorphisms in malaria-endemic populations.

Authors:  Jennifer A Greene; Ann M Moormann; John Vulule; Moses J Bockarie; Peter A Zimmerman; James W Kazura
Journal:  Malar J       Date:  2009-03-24       Impact factor: 2.979

Review 10.  Filariasis and lymphoedema.

Authors:  K M Pfarr; A Y Debrah; S Specht; A Hoerauf
Journal:  Parasite Immunol       Date:  2009-11       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.